- Novo Nordisk A/S, Denmark
The overall objective is to develop an in silico model of the blood coagulation system that can be used as a tool for improving the understanding of coagulation processes and supporting the development of new haemostatic agents. The complexity of the modeled system range from systems modeling homogeneous solutions to systems which involve flow and activated surfaces.
|Period||01/08/07 → 31/07/10|
|Financing source||Forskningsprojekter - Erhvervsforskere, VTU|
|Research programme||Forskningsprojekter - Erhvervsforskere, VTU|
|Amount||1,340,000.00 Danish Krone|